��ɫ��

��ɫ��

Donate To Research Join The AAN

Events

Resources For

Abstract Details

Title Efficacy of Memantine in Moderate to Severe Alzheimer's Disease: Time-to-Event Analysis in a Pooled Population

Topic Aging and Dementia

Presentation(s) (-)

Poster/Presentation
Number 226

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Michael Tocco	No disclosure on file
Ayaz M. Khawaja, MD	Dr. Khawaja has nothing to disclose.
Suzanne Hendrix, PhD (Pentara)	Dr. Hendrix has received personal compensation for serving as an employee of Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pentara Corporation. The institution of Dr. Hendrix has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pentara Corporation. Dr. Hendrix has or had stock in Pentara.
Michael L. Miller, PhD	No disclosure on file
Vojislav Pejovic, PhD (PMCG)	No disclosure on file
Stephen M. Graham, PhD (Forest Laboratories)	No disclosure on file